A few words about cookies

Ladies and Gentlemen, from May 25, 2018, the Regulation of the European Parliament and of the Council of the European Union 2016/679 of April 27, 2016 (GDPR) has been in force. We need your consent to the processing of your personal data, including those stored in cookies.

Necessary

Marketing

Statistics

Preferences

Necessary

Necessary cookies contribute to the usability of the website by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Marketing

Marketing cookies are used to track users across websites. The aim is to display advertising that is relevant and interesting to individual users and therefore more valuable to publishers and third-party advertisers.

Statistics

Statistical cookies help website owners understand how different users behave on the site by collecting and reporting anonymous information.

Preferences

Preference cookies enable a website to remember information that changes the look or feel of the website, such as your preferred language or the region in which you are located.

Ladies and Gentlemen, from May 25, 2018, the Regulation of the European Parliament and of the Council of the European Union 2016/679 of April 27, 2016 (GDPR) has been in force. We need your consent to the processing of your personal data, including those stored in cookies. Below is the full range of information on this topic.

By clicking the 'Allow all' button, you consent to the use of your data. I agree to the storage of the so-called cookies and for the processing of my personal data left when I use products and services provided electronically as part of websites, services and other functionalities, including information and other parameters saved in cookies for analytical purposes by Dalkia Polska Sp. z o. o., entities of the Dalkia capital group and business partners of the Dalkia group.

Purposes of data processing 1. providing services electronically 2. adapting the content of websites to preferences and interests 3. detecting bots and abuses in services 4. statistical measurements and improving services (analytical purposes) Legal basis for data processing 1. analytical purposes - consent 2. provision of services by electronic means - necessity of data to provide the service 3. other purposes - legitimate interest of the data controller Data recipients Entities processing data on behalf of the data controller, including entities of the Dalkia capital group and business partners of the Dakia Polska group and entities authorized to obtain data on the basis of applicable law laws. Rights of the data subject The right to request rectification, deletion or limitation of data processing; the right to withdraw consent to the processing of personal data.

We also inform you that by using this Website without changing the settings of the software/browser used, you consent to the storage of cookies and similar technologies on your end device and the use of the information stored in them. * Profiling will use at least: the following data: your IP address, request URL, domain name, device identifier, and other similar information.

IFOTAM Łódź

Implementation of work in the pharmaceutical industry in the field of comprehensive execution of new installations including the construction of rooms and the qualification of installations and rooms.

Poland

The challenge

Implementation of work in the pharmaceutical industry (cooperation with Magfarm Group) - production of oncology drugs based on innovative cytostatic pharmaceutical substances.

Dalkia Polska Solutions dealt with complex execution of mechanical ventilation installation, air-conditioning installation, technological heat and chilled water installation, technological steam and compressed air installation, cold and hot water installation, sanitary, technological and contaminated sewage installation, hydrant installation, electric installation and automation, together with development of clean rooms with walls and pharmaceutical ceilings and qualification of installations and rooms. In the project it was important to adapt the installation in the already existing space and to perform the installation in the added part of the plant. During the implementation phase, it was also very important to meet the pharmaceutical requirements and perform the qualification of installations and rooms.

Solution

  • Installation of mechanical ventilation and air conditioning including for clean rooms in class C and D:
    • reconstruction of existing systems with relocation of air handling units with total capacity of ~ 19 500 m3/h
    • supply and installation of a new supply air handling unit with a capacity of 21 000 m3/h and two exhaust air handling units with BI-BO filters with a total capacity of 21 500 m3/h,
    • Construction of all new ventilation ducts with HEPA filtered air intakes,
    • execution of ventilation and air conditioning installation for Trafo and UPS rooms with capacity of ~ 6 800 m3/h,
    • installation of freon air conditioning in the office part, 
  • Technological heat installation - adaptation to new layouts and rooms, 
  • Chilled water installation - construction of a machine room and extension of the installation by two new units (up to approx. 1,900 kW) to service the coolers in the air handling units, fan coil units and clean media technology equipment,
  • Construction of a complete technological steam and condensate plant, based on a newly installed external container boiler house with a maximum capacity of 2000 kg/h and consisting of three steam circuits: 3 bar(g), 5 bar(g) and 8 bar(g),
  • Construction of a complete compressed air installation based on a newly installed air-cooled oil-free screw compressor with a capacity of up to 8.8 m3/min, along with a 3.15 m3 buffer tank and adsorption dryer,
  • Modernisation of the cold water, hot water and sewerage systems including the installation of sanitary, technological, and contaminated sewerage systems,
  • Equipped all installations with an automatic system for controlling and supervising their operation and connected to the BMS system.

Key figures

  • Facility area: 2 500 m2
  • Total heating capacity: more than 1,200 kW
  • Extension of the chilled water plant: more than 1400 kW

Selected projects

Mysłowice Combined Heat and Power Plant

As part of its investment strategy, Dalkia Polska Energia decarbonizes sources of heat. The Mysłowice Combined Heat and Power Plant is generating heat in a more and more ecological way.

Szopienice Combined Heat and Power Plant

As part of its investment strategy, Dalkia Polska Energia decarbonizes sources of heat. The Szopienice Combined Heat and Power Plant is generating heat in a more and more ecological way.

Starpharma

Starpharma Sp. z o.o. is a modern Polish pharmaceutical company that was founded in 2010. It manufactures OTC medications, medical devices, medicinal products, dietary supplements, cosmetics, and functional confectionery. The company operates both in Poland and abroad, supplying products to more than 40 countries all over the world.

Lesznowola